# Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

> **NCT06263998** · PHASE1 · RECRUITING · sponsor: **Huons Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Xerophthalmia

## Interventions

- **DRUG:** NCP112
- **DRUG:** NCP112 Placebo

## Key facts

- **NCT ID:** NCT06263998
- **Lead sponsor:** Huons Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-11
- **Primary completion:** 2025-11-28
- **Final completion:** 2026-01-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06263998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06263998, "Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06263998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*